Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Mucosal inflammation
ADR ID BADD_A02864
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.06      Mucosal findings abnormal
08.01.06.002      Mucosal inflammation
Description An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY). [MeSH]
MedDRA Code 10028116
MeSH ID D052016
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Inflammation mucous membrane | Mucosal inflammation | Mucosal inflammation NOS | Mucosal sores | Mucositis | Mucositis NOS | Mucositides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.003694%
BADD_D00064Alemtuzumab--
BADD_D00076Allopurinol--
BADD_D00132Amphotericin b0.000094%
BADD_D00137Amsacrine--
BADD_D00157Aprepitant0.000081%
BADD_D00168Arsenic--
BADD_D00193Axitinib0.005070%
BADD_D00194Azacitidine0.000616%
BADD_D00198Azelastine--
BADD_D00203Azithromycin--
BADD_D00204Azithromycin dihydrate--
BADD_D00205Azithromycin monohydrate--
BADD_D00230Bendamustine0.000280%
BADD_D00231Bendamustine hydrochloride--
BADD_D00280Bleomycin--
BADD_D00318Busulfan0.000616%
BADD_D00328Cabazitaxel--
BADD_D00330Cabozantinib0.013543%
BADD_D00331Cabozantinib s-malate--
BADD_D00349Capecitabine0.017853%
BADD_D00364Carboplatin0.000728%
BADD_D00367Carfilzomib--
BADD_D00376Caspofungin0.000150%
BADD_D00377Caspofungin acetate--
BADD_D00417Cetirizine0.000029%
BADD_D00422Cetuximab--
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D00429Chlorambucil--
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages